SEGMENTS (Tables)

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the years ended December 31, 2022 and 2021:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended on December 31, 2022
Revenue	$	3,088,628		$	69,915		$	753,651		$	568,248		$	4,480,442
Cost of Sales		(3,016,200	)		(23,423	)		(523,534	)		(168,833	)		(3,731,990	)
Gross Margin		72,428			46,492			230,117			399,415			748,452
Operating Expenses		(1,479,674	)		(414,167	)		(850,044	)		(5,093,941	)		(7,837,826	)
Operating Income (Loss)		(1,407,246	)		(367,675	)		(619,927	)		(4,694,526	)		(7,089,374	)
Other Income (Expense)		5,885			(1,359,977	)		(4,669,309	)		(33,099,730	)		(39,123,131	)
Net Income (Loss) Before Income Tax		(1,401,361	)		(1,727,652	)		(5,289,236	)		(37,794,256	)		(46,212,505	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended on December 31, 2021
Revenue	$	14,213,379		$	-		$	5,543,066		$	42,377		$	19,798,822
Cost of Sales		(11,073,756	)		-			(214,019	)		(14,039	)		(11,301,814	)
Gross Margin		3,139,623			-			5,329,047			28,338			8,497,008
Operating Expenses		(1,136,031	)		(183,429	)		(3,624,200	)		(18,547,470	)		(23,491,130	)
Operating Income (Loss)		2,003,592			(183,429	)		1,704,847			(18,519,132	)		(14,994,122	)
Other Income (Expense)		(8,955	)		1,286,962			(39,265,445	)		(65,502,017	)		(103,489,455	)
Net Income (Loss) Before Income Tax		1,994,637			1,103,533			(37,560,598	)		(84,021,149	)		(118,483,577	)
December 31, 2022
Cash and Restricted Cash	$	2,592,577		$	514,260		$	1,338,404		$	14,076,662		$	18,521,903
Total Assets		57,951,324			3,184,416			4,861,615			87,492,981			153,490,336
December 31, 2021
Cash and Restricted Cash	$	7,493,921		$	245,780		$	2,629,464		$	50,433,014		$	60,802,179
Total Assets		55,465,600			2,199,466			11,056,779			115,488,298			184,210,143